MedCords Competitors or Alternatives

MedCords's top competitors include Trusted Tablets, High Times and Ubiquiti.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

MedCords's company profile

Shreyans Mehta

Co-Founder

80/100
$378K
1
MedCords's Competitor - Trusted Tablets logo

CEO

- -
25 - 100
- -
$5M - 25M
2
MedCords's Competitor - High Times logo

Peter Horvath

CEO

55/100
25 - 100
$10M
$5M - 25M
3
MedCords's Competitor - Ubiquiti logo

Robert J. Pera

Chairman & CEO

68/100
1,380
$105.6M
$2.2B
4
MedCords's Competitor - AltMed logo

John Tipton

CEO

84/100
250 - 500
$35.4M
$25M - 100M
5
MedCords's Competitor - Ability Pharma logo

Carles Domenech

Co-Founder & CEO

86/100
25 - 100
$25.5M
$5M - 25M

MedCords VS Trusted Tablets

Trusted Tablets is MedCords's biggest rival. Trusted Tablets was founded in 2007, and is headquartered in Larnaca, Larnarca District. Like MedCords, Trusted Tablets also works within the Pharmaceuticals & Biotechnology sector. Trusted Tablets generates $5.6M more revenue vs. MedCords.

MedCords VS High Times

High Times is one of MedCords's top competitors. High Times's headquarters is in Los Angeles, California, and was founded in 1974. Like MedCords, High Times also works within the Pharmaceuticals & Biotechnology sector. High Times generates ∞% of MedCords's revenue.

MedCords VS Ubiquiti

Ubiquiti is seen as one of MedCords's top competitors. Ubiquiti is a Public company that was founded in 2003 in New York, New York. Ubiquiti operates in the Computers, Peripherals, Networking and Electronic Equipment industry. Compared to MedCords, Ubiquiti has 1,380 more employees.

Frequently Asked Questions about MedCords

  1. Who are MedCords's top competitors?

    MedCords's top 3 competitors are Trusted Tablets, High Times, Ubiquiti.
  2. Who is similar to MedCords?

    Trusted Tablets is the most similar to MedCords. High Times and Ubiquiti are also similar to MedCords.
  1. Are MedCords and Trusted Tablets competitors?

    Yes, Trusted Tablets is one of MedCords’s top competitors.